University of Miami Sylvester Comprehensive Cancer Center

 

Leukemia
21:24

2024 ASH Annual Meeting Insights Hub

ASH 2024 Insights: Venetoclax + Aza for 1L Younger AML Pts Independent of Fitness for Intensive Therapy

FEATURING Justin Watts
  • 9 views
  • December 16, 2024
07:56

University of Miami Sylvester Comprehensive Cancer Center

Role of Mutations in AML: FLT3-ITD Mutation Confers Poor Prognosis but is Actionable

FEATURING Sangeetha Venugopal
  • 187 views
  • March 18, 2024
  • 1